Biologic drugs are increasingly complex, creating numerous challenges for biopharmaceutical companies from higher candidate failure rates to expression and manufacturing obstacles. Our Mammalian and Microbial expression systems and processes address the needs of more complex candidates including vector design, cell line and strain selection and analytics to measure product quality attributes. Case studies will be discussed demonstrating the range of expression capabilities across mammalian and microbial derived molecules.


Content Type: Presentation (on-demand)
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center